RxDoctor Payments Data

Kondie Lykins, PA

Physician Assistant · Pinehurst, NCNPI 1437515335

Payments from drug & device makers

$1,417in general payments, 2019–2025

Across 47 payments — averaging $30.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$601
  • Novo Nordisk$504
  • AbbVie$57
  • Mylan Specialty L.p.$47
  • Lilly USA, LLC$44
  • Corium, LLC$43
  • plus $122 from 5 others

What the payments were for

  • Food & beverage$1,38598%
  • Education$322%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,417 in reported general payments places this provider in the 75th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$20,980
Medicare patients
220
Services billed
596

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol24$28,372
OzempicSemaglutide16$15,391
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen98$2,049
Methylprednisolone218$1,361
Albuterol Sulfate HfaAlbuterol Sulfate62$1,243
Atorvastatin Calcium51$449
Gabapentin42$398
Omeprazole24$363
Doxycycline Hyclate31$285
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav33$266
Amoxicillin69$228
Ondansetron OdtOndansetron13$194
Cefdinir18$180
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst19$177
Cephalexin41$172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$601$28,37224 claims
Novo NordiskOzempic$504$15,39116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Pinehurst

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →